BioCentury
ARTICLE | Company News

Isis Pharmaceuticals, SQI Diagnostics deal

November 11, 2013 8:00 AM UTC

SQI will use its Ig Plex multiplexing immunogenicity technology to develop a multiplex anti-drug antibody assay for Isis. Ig Plex allows for simultaneous quantification of Ig isotype and subclass for multiple therapeutic proteins in the same test well. The companies declined to disclose further details. ...